Lev Gerlovin

Vice President

Mr. Lev Gerlovin has more than 20 years of consulting experience across strategic planning, litigation, and policy spheres. His recent focus has been in leading strategy engagements for a diverse set of clients, including major pharmaceutical and biotechnology manufacturers, distributors, health plan providers, and industry groups.

Mr. Gerlovin has managed projects spanning commercial strategy, pricing and market access, product design and optimization, product launch, portfolio lifecycle management, channels and distribution, sales and marketing effectiveness, and organizational design. He has broad therapeutic category experience, particularly in diabetes, endocrinology, neurology, psychiatry, hematology, oncology, immunology, rare diseases, and cell and gene therapy. He leads CRA’s Life Sciences 2030 Idea Leadership Platform.

Selected engagements

  • 01
    Value proposition reimbursement pathways for a DTx
    A digital therapeutics company hired CRA to understand a medical device price and market access (PMA) potential.
    View engagement
  • 02
    Assessment of global supply and demand in diagnostics arbitration
    CRA provided expert reports and hearing testimony on behalf of the respondent in an arbitration arising from an alleged breach of a supply agreement related to...
    View engagement